Maynard Um
-
-
-
-
-
-
-
Sonoma Pharmaceuticals (SNOA) Misses Q3 EPS by 43c
-
-
-
-
-
-
-
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results
-
-
-
-
-
-
-
Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains
-
-
-
-
-
-
-
Sonoma Pharmaceuticals (SNOA) Tops Q3 EPS by 6c
-
-
-
-
-
-
-
Sonoma Pharmaceuticals, Inc. (SNOA) Misses Q2 EPS by 54c
-
-
-
-
-
-
-
Sonoma Pharmaceuticals (SNOA) Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn-Based Solution
-
-
-
-
-
-
-
Sonoma Pharmaceuticals (SNOA) Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States
-
401,140 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

